• ENVI and GreenLight Biosciences File Definitive Proxy Statement/Prospectus; February 1st, 2022, Meeting to Approve Proposed Business Combination

    12 days ago - By Green Light Biosciences

    Boston, January 14, 2022/ - Environmental Impact Acquisition Corporation , a publicly-traded special purpose acquisition company, announced today that ENVI's definitive proxy statement/prospectus relating to the previously announced business combination with GreenLight Biosciences, Inc. , a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health, has been filed with the U.S. Securities and Exchange Commission on January 13, 2022.
    ENVI has commenced mailing of the Proxy Statement and a notice and voting instruction form or a proxy card...
    Read more ...